Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 CAD | +1.42% | +0.47% | -20.74% |
Apr. 17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
Apr. 17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- NGEN Stock
- Charts NervGen Pharma Corp.